You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Brian T Do1, Matthew G Vander Heiden2
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA; Department of Biology, MIT, Cambridge, MA 02139, USA; Harvard-MIT Health Sciences and Technology, Cambridge, MA 02139, USA.
Pancreatic cancer cells adapt their metabolism to survive. Targeting the enzyme GOT2 reveals new therapeutic strategies for pancreatic ductal adenocarcinoma by understanding its metabolic vulnerabilities.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: